- 全部删除
您的购物车当前为空
MZP-55 is a selective BRD3/4 degrader based on PROTAC technology(Brd4BD2 with Kd of 8 nM)


为众多的药物研发团队赋能,
让新药发现更简单!
MZP-55 is a selective BRD3/4 degrader based on PROTAC technology(Brd4BD2 with Kd of 8 nM)
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 4,570 | 待询 | |
| 10 mg | ¥ 6,990 | 待询 | |
| 25 mg | ¥ 13,300 | 待询 | |
| 50 mg | 待询 | 待询 | |
| 100 mg | 待询 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 4,990 | 待询 |
MZP-55 相关产品
| 产品描述 | MZP-55 is a selective BRD3/4 degrader based on PROTAC technology(Brd4BD2 with Kd of 8 nM) |
| 靶点活性 | BRD4 BD2:(kd)8 nM |
| 体外活性 | MZP-55 binds to VHL-EloC-EloB protein (VCB) with a Kd of 105 ± 24 nM. MZP-55 shows an inhibitory activity against MV4;11 and HL60 cells, with pEC50s of 7.31 ± 0.03 and 6.57 ± 0.02, respectively[1]. |
| 分子量 | 1080.73 |
| 分子式 | C57H70ClN7O10S |
| CAS No. | 2010159-48-3 |
| 密度 | 1.268 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (46.27 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容